Alcidion to Acquire Patient Administration System (PAS) Provider, Silverlink

Alcidion LtdAlcidion - provider of the Electronic Patient Record (EPR) platform Miya Precision - has today acquired Silverlink PCS Software Limited (Silverlink). The acquisition provides Alcidion with Patient Administration System (PAS) capabilities to complement its existing clinical capabilities in Miya Precision and represents a significant statement of intent in the EPR sector. The combination of the two products alongside their network of partners will give Alcidion the capabilities to deliver a cloud-native, modern and modular Electronic Patient Record (EPR/EMR) system to the NHS.

NHSX have outlined that EPR systems are the building blocks of good digital healthcare. Alcidion will now be a key player in positively improving what is available to NHS trusts, helping individual providers and Integrated Care Systems (ICS) improve their digital maturity.

Kate Quirke, Alcidion Group Managing Director said: "This acquisition is very exciting and aligns with our overall intention to enhance the services we can offer the NHS. We welcome the Silverlink team who together with our own senior leadership team have decades of product development and implementation experience in PAS. These skills and experience make this partnership a perfect fit."

Lynette Ousby, UK Managing Director added: "We are excited to bring on board the experience and technology of the Silverlink team, which complements the work we have been doing at Alcidion with our Miya Precision platform. We believe that together we have a modern and compelling solution that delivers something different to the NHS. Our approach of separating data and application layers allows us to deliver an open, modular and flexible EPR ecosystem that can be easily configured to the specific needs of each trust. This further signals our intent to bring a compelling alternative to how trusts and ICS’ accelerate their digital maturity."

About Patient Administration Systems

A PAS is the foundation of hospital IT systems and one of the first software solutions widely deployed in healthcare. A PAS captures all non-clinical information used in the daily management of a hospital including registrations, admissions, bed occupancy and discharge. It holds the key data for administration and reporting of hospital activity.

It is estimated that approximately 60+ UK Trusts will need to upgrade their existing PAS software over the next five years. The broadened product suite allows Alcidion’s existing customers to rapidly take advantage of additional services to support the NHS’s stated digital transformation strategy of openness, modularity, modern and cloud-native EPRs.

Completion of the transaction is expected to occur on or around 15 December 2021.

About Silverlink

Founded in 1994, Silverlink is the UK's leading specialist PAS provider servicing the NHS with their flagship product Patient Case System (PCS). PCS is recognised as being a flexible, cost-effective solution that can easily integrate with other clinical systems to support an ecosystem approach, enabling the benefits of a full EPR without single supplier lock-in.

Silverlink has long-standing customer relationships with 12 NHS Trusts, 11 of which are new relationships for Alcidion, with the remaining Trust being an existing user of Miya Observations and Assessments.

About Alcidion

Alcidion Group Limited (Alcidion) has a simple purpose, that is, to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia, and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...